U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07609953) titled 'Cognitive Behavioral Therapy Added to Risperidone for Schizophrenia' on May 20.
Brief Summary: This study evaluated whether cognitive behavioral therapy (CBT), when added to risperidone treatment, improves cognitive function and serum brain-derived neurotrophic factor (BDNF) levels in patients with schizophrenia. Participants were adults with stable-phase schizophrenia who were receiving risperidone therapy. They were assigned to either a control group receiving risperidone alone or an intervention group receiving risperidone plus 10 weekly CBT sessions.
Cognitive function was assessed using the Indonesian version of the Cognitive A...